+44 203 371 1100
+44 203 371 1100
Credit Sector:- Health Care
Country:- United States
Bond Document:- https://www.bondpdf.com
In order to view the complete data, please login here
| Announcement Date | CA Type | CA Impact | CA Event | ISIN |
|---|---|---|---|---|
| 08-Oct-2023 | Propose Acquisition | Target Name | Mirati Therapeutics, Inc. | US00214WAE12 |
| Bristol-Myers Squibb Company today announced that it intends to acquire Mirati Therapeutics, Inc. | ||||
| 30-Oct-2023 | New Bond | - | - | US110122DY15 |
| Bristol-Myers Squibb Company today announced that it has issued USD 1MMM, 5.750% Fixed bond due 01-Feb-2031. | ||||
| 13-Nov-2023 | Final Maturity | - | - | US110122DT20 |
| Bristol-Myers Squibb Company today announced that the bond has reached its full maturity for USD 1500MM, 0.537% Fixed rate bond due 13-Nov-2023. | ||||
| 03-Apr-2024 | Final Maturity | - | - | US110122DB12 |
| Bristol-Myers Squibb Company today announced that the bond has reached its full maturity for USD 882510M, 3.625% Fixed rate bond due 15-May-2024. | ||||
| 03-Apr-2024 | Final Maturity | - | - | US110122BM94 |
| Bristol-Myers Squibb Company today announced that the bond has reached its full maturity for USD 882510M, 3.625% Fixed rate bond due 15-May-2024. | ||||
All of the financial data available on this page is sourced from FactEntry.